The Daily Pulse

Health• Updated

Supreme Court Questions Cancer Drug Costs as New Dengue Forecasting Tool Emerges

Reported by Rohit Yadav (Staff Writer) · The Hindu - Health ·

Unconfirmed — Reported by one source so far

Reported by one source so far

Worth knowing
Supreme Court Questions Cancer Drug Costs as New Dengue Forecasting Tool EmergesRepresentative image · Wikimedia Commons

UPDATE - follow-up to Health Wrap Episode 53 discuss cancer drug pricing, medicine misuse and dengue: The newest podcast episode from The Hindu examines major concerns raised by the Supreme Court regarding heavy markups on critical oncology treatments, alongside new tools for tracking vector-borne illness.

Drug Pricing Concerns

Hosted by Senior Assistant Editor Zubeda Hamid and Senior Reporter Athira Elssa Johnson, the latest discussion highlights a case where an oncology treatment costing about twenty-seven hundred rupees to supply was sold to patients for twenty-seven thousand rupees. The bench of judges termed this massive gap an open daylight robbery. The judiciary also focused on hospitals forcing patients to purchase supplies exclusively from in-house pharmacies, proposing a fixed sixteen percent profit margin, and questioned how strictly the Drugs Prices Control Order is being enforced.

Health Risks

Beyond costs, the episode warns about the dangers of taking painkillers and antibiotics without proper medical guidance. Misusing painkillers can lead to serious kidney damage, while taking antibiotics needlessly creates drug resistance that makes future infections much harder to treat.

Dengue Tracking

In Keralam, experts at the Institute of Advanced Virology are building a machine learning tool to predict dengue outbreaks. This warning system uses past disease records along with weather details like rain, temperature, and air moisture to create weekly forecasts for every district. Trained on data gathered from March 2020 through February 2026, the tool hopes to help officials spot outbreaks early, manage mosquitoes better, and warn the public in time once testing finishes.

Context

Drug pricing in India is closely regulated to keep essential treatments affordable for the general public, though large gaps can sometimes emerge through various distribution channels. Meanwhile, vector-borne illnesses like dengue tend to surge during specific seasonal shifts, making early prediction tools helpful for local health departments trying to stop outbreaks before they grow.

Background: This follows an earlier report, covered earlier on 04 Oct 2026: 'Health Wrap Episode 53 discuss cancer drug pricing, medicine misuse and dengue'. Read the earlier report →

What changed since yesterday

  1. Supreme Court Slams Cancer Drug Prices While New Keralam Dengue Tool Takes Shape
  2. Latest

    Supreme Court Questions Cancer Drug Costs as New Dengue Forecasting Tool Emerges

ExplainerWhy this matters

What Happened

The Supreme Court has raised hard questions about the massive price gap between what it costs to make essential cancer treatments and what patients actually pay at retail counters, while also reviewing how hospitals sell drugs.

Why It Matters

High medicine costs place a heavy financial burden on families dealing with serious illnesses like cancer, making affordable access a major public welfare issue. At the same time, unregulated antibiotic use threatens public health by creating drug-resistant infections that standard treatments cannot cure.

What Happens Next

The court's scrutiny could lead to tighter checks on drug markups and hospital pharmacy rules, while researchers continue to test and evaluate the new weather-based dengue forecasting tool before health authorities can officially adopt it.

Read more at The Hindu - Health →